{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:26:26Z","timestamp":1770060386284,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00296-020-04730-1","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T10:03:00Z","timestamp":1603879380000},"page":"439-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-2228","authenticated-orcid":false,"given":"Burak","family":"Ince","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-9252","authenticated-orcid":false,"given":"Selay","family":"Artan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9357-0456","authenticated-orcid":false,"given":"Yasemin","family":"Yalcinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5659-3955","authenticated-orcid":false,"given":"Bahar","family":"Artim-Esen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-3720","authenticated-orcid":false,"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-256X","authenticated-orcid":false,"given":"Lale","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-5583","authenticated-orcid":false,"given":"Murat","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"issue":"1","key":"4730_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4730_CR2","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-gay","year":"2009","unstructured":"Gonzalez-gay MA, Vazquez-rodriguez TR, Lopez-diaz MJ, Miranda-filloy JA, Gonzalez-juanatey C, Martin J et al (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61(10):1454\u20131461","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4730_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13075-017-1479-6","volume":"19","author":"LK Brekke","year":"2017","unstructured":"Brekke LK, Diamantopoulos AP, Fevang BT, Abetamus J, Espero E, Gjesdal CG (2017) Incidence of giant cell arteritis in Western Norway 1972\u20132012: a retrospective cohort study. Arthritis Res Ther 19(1):278","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4730_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","volume":"86","author":"MA Gonzalez-gay","year":"2007","unstructured":"Gonzalez-gay MA, Miranda-filloy JA, Lopez-diaz MJ, Perez-alvarez R, Gonzalez-juanatey C, Sanchez-andrade A et al (2007) Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore) 86(2):61\u201368","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4730_CR5","first-page":"830","volume":"27","author":"ON Pamuk","year":"2009","unstructured":"Pamuk ON, Donmez S, Karahan B, Pamuk GE, Cakir N (2009) Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: clinical features and epidemiological data. Clin Exp Rheumatol 27(5):830\u2013833","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4730_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","volume":"123","author":"C Salvarani","year":"1995","unstructured":"Salvarani C, Gabriel SE, O\u2019fallon WM, Hunder GG (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 123(3):192\u2013194","journal-title":"Ann Intern Med."},{"issue":"4","key":"4730_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/art.11195","volume":"49","author":"S Kobayashi","year":"2003","unstructured":"Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K et al (2003) Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49(4):594\u2013598","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4730_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"4730_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez058.017","author":"C Ponte","year":"2019","unstructured":"Ponte C, Grayson P, Suppiah R, Robson J, Gribbons K, Craven A et al (2019) 007. \u00b0Classification criteria for large-vessel vasculitis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kez058.017","journal-title":"Rheumatology"},{"issue":"1","key":"4730_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","volume":"55","author":"AP Diamantopoulos","year":"2016","unstructured":"Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G (2016) The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford) 55(1):66\u201370","journal-title":"Rheumatology (Oxford)"},{"issue":"26","key":"4730_CR11","doi-asserted-by":"publisher","first-page":"e3818","DOI":"10.1097\/MD.0000000000003818","volume":"95","author":"H De Boysson","year":"2016","unstructured":"De Boysson H, Lambert M, Liozon E, Boutemy J, Maigne G, Ollivier Y et al (2016) Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern. Medicine (Baltimore) 95(26):e3818","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4730_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D et al (2017) Trial of Tocilizumab in giant-cell arteritis. New Engl J Med 377(4):317\u2013328","journal-title":"New Engl J Med"},{"issue":"90","key":"4730_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20900","volume":"20","author":"R Luqmani","year":"2016","unstructured":"Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M et al (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1\u2013238","journal-title":"Health Technol Assess"},{"key":"4730_CR14","doi-asserted-by":"crossref","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, De Boysson H, Brouwer E, et al (2019) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis","DOI":"10.1136\/annrheumdis-2019-eular.8496"},{"key":"4730_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex062.337","author":"F Laskou","year":"2017","unstructured":"Laskou F, Koduri G, Lever E, Stapleton P, Dasgupta B (2017) 330 \u00b0Flare rates in giant cell arteritis: a single-centre long-term retrospective study. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kex062.337","journal-title":"Rheumatology"},{"issue":"2","key":"4730_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2016.05.009","volume":"46","author":"MS Broder","year":"2016","unstructured":"Broder MS, Sarsour K, Chang E, Collinson N, Tuckwell K, Napalkov P et al (2016) Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis. Semin Arthritis Rheum 46(2):246\u2013252","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4730_CR17","first-page":"495","volume":"19","author":"RF Spiera","year":"2001","unstructured":"Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG et al (2001) A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 19(5):495\u2013501","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"4730_CR18","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"AD Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF, Hernandez-garcia C, Fernandez-Gutierrez B, Lavalley MP et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56(8):2789\u20132797","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4730_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/acr.22942","volume":"69","author":"M Catanoso","year":"2017","unstructured":"Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A et al (2017) Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in northern Italy during a 26-year period. Arthritis Care Res (Hoboken) 69(3):430\u2013438","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"4730_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.20227","volume":"51","author":"C Salvarani","year":"2004","unstructured":"Salvarani C, Crowson CS, O\u2019fallon WM, Hunder GG, Gabriel SE (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 51(2):264\u2013268","journal-title":"Arthritis Rheum."},{"issue":"Suppl_2","key":"4730_CR21","doi-asserted-by":"publisher","first-page":"ii63","DOI":"10.1093\/rheumatology\/kex428","volume":"57","author":"I Vodopivec","year":"2018","unstructured":"Vodopivec I, Rizzo JF (2018) 3RD. Ophthalmic manifestations of giant cell arteritis. Rheumatology (Oxford) 57(Suppl_2):ii63\u2013ii72","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"4730_CR22","first-page":"753","volume":"56","author":"L Li","year":"2017","unstructured":"Li L, Neogi T, Jick S (2017) Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford) 56(5):753\u2013762","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4730_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/rheumatology\/kex397","volume":"57","author":"TA Kermani","year":"2018","unstructured":"Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA et al (2018) Evaluation of damage in giant cell arteritis. Rheumatology (Oxford) 57(2):322\u2013328","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4730_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/art.1780400222","volume":"40","author":"AR Exley","year":"1997","unstructured":"Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO et al (1997) Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40(2):371\u2013380","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4730_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1136\/annrheumdis-2018-214755","volume":"78","author":"L Ehlers","year":"2019","unstructured":"Ehlers L, Askling J, Bijlsma HW, Cid MC, Cutolo M, Dasgupta B et al (2019) 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Ann Rheum Dis 78(9):1160\u20131166","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4730_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C et al (2012) 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheum 64(4):943\u2013954","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4730_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","volume":"8","author":"C Salvarani","year":"2012","unstructured":"Salvarani C, Pipitone N, Versari A, Hunder GG (2012) Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 8(9):509\u2013521","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"4730_CR28","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.amjmed.2015.06.001","volume":"128","author":"BA Cunha","year":"2015","unstructured":"Cunha BA, Lortholary O, Cunha CB (2015) Fever of unknown origin: a clinical approach. Am J Med 128(10):1138 ((e1\u2013e15))","journal-title":"Am J Med"},{"key":"4730_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez058.051","author":"E Rubenstein","year":"2019","unstructured":"Rubenstein E, Maldini C, Gonzalez-chiappe S, Chevret S, Mahr A (2019) Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kez058.051","journal-title":"Rheumatology"},{"issue":"2","key":"4730_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","volume":"36","author":"C Font","year":"1997","unstructured":"Font C, Cid MC, Coll-vinent B, Lopez-soto A, Grau JM (1997) Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 36(2):251\u2013254","journal-title":"Br J Rheumatol"},{"issue":"1","key":"4730_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","volume":"41","author":"MC Cid","year":"1998","unstructured":"Cid MC, Font C, Oristrell J, De la Sierra A, Coll-vinent B, Lopez-soto A et al (1998) Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41(1):26\u201332","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4730_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.1780400105","volume":"40","author":"CM Weyand","year":"1997","unstructured":"Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ (1997) Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 40(1):19\u201326","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4730_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/BOR.0b013e32833ee946","volume":"23","author":"CM Weyand","year":"2011","unstructured":"Weyand CM, Younge BR, Goronzy JJ (2011) IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 23(1):43\u201349","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"4730_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s40744-019-00180-9","volume":"6","author":"JH Best","year":"2019","unstructured":"Best JH, Kong AM, Unizony S, Tran O, Michalska M (2019) Risk of potential glucocorticoid-related adverse events in patients with giant cell arteritis: results from a USA-based electronic health records database. Rheumatol Ther 6(4):599\u2013610","journal-title":"Rheumatol Ther"},{"issue":"4","key":"4730_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/rheumatology\/key325","volume":"58","author":"P Macchioni","year":"2019","unstructured":"Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N et al (2019) Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study. Rheumatology (Oxford) 58(4):609\u2013616","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"4730_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.autrev.2019.06.003","volume":"18","author":"G Nesher","year":"2019","unstructured":"Nesher G, Poltorak V, Hindi I, Nesher R, Dror Y, Orbach H et al (2019) Survival of patient with giant cell arteritis: impact of vision loss and treatment with aspirin. Autoimmun Rev 18(8):831\u2013834","journal-title":"Autoimmun Rev"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-020-04730-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T18:10:10Z","timestamp":1611598210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-020-04730-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4730"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04730-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by Istanbul University, Istanbul Faculty of Medicine Ethics Committee (No. 1494-2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not obtained due to retrospective evaluation of cases and presence of deaths and lost to follow-ups.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}